Short answer
CVS Health (CVS) filed its Q2 2025 10-Q quarterly report on Jul 31, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $98.9B (up 8.4% year over year) with net income of $1.0B.
Q2 2025 key financials · XBRL
- Revenue
- $98.9B
- +8.4% YoY · +4.6% QoQ
- Net income
- $1.0B
- −42.3% YoY · −42.6% QoQ
- Operating margin
- 2.4%
- EPS (diluted)
- $0.80
- −42.9% YoY · −43.3% QoQ
Source: XBRL data from the CVS Health (CVS) Q2 2025 10-Q on SEC EDGAR. USD.
CVS Health Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Cash position and operating cash flow changes not mentioned
- No management commentary on near-term outlook or guidance included
Risk Factors
- No material changes to risk factors from most recent 10-K
- Continued regulatory compliance risks including healthcare laws and data privacy regulations
- Ongoing operational risks from competitive pharmacy and healthcare market pressures
- Financial risk from debt maturities and liquidity management remain consistent
- Forward-looking statements subject to uncertainty, no new risk disclosures
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CVS Health quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.